Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 115 entries
Sorted by: Best Match Show Resources per page
Recent developments in the management of germ cell tumors.

Current opinion in oncology

Msaouel P, Bilen MA, Zhang M, Campbell M, Wang J, Tu SM.
PMID: 28151756
Curr Opin Oncol. 2017 May;29(3):172-178. doi: 10.1097/CCO.0000000000000361.

PURPOSE OF REVIEW: In the present review, we summarize the recent developments in the management of germ cell tumors (GCTs).RECENT FINDINGS: Treatment-related acute and late-onset toxicity remains a key challenge in the management of GCTs. Recent data show that...

Cite
Msaouel P, Bilen MA, Zhang M, et al. Recent developments in the management of germ cell tumors. Curr Opin Oncol. 2017;29(3):172-178doi: 10.1097/CCO.0000000000000361.
Msaouel, P., Bilen, M. A., Zhang, M., Campbell, M., Wang, J., & Tu, S. M. (2017). Recent developments in the management of germ cell tumors. Current opinion in oncology, 29(3), 172-178. https://doi.org/10.1097/CCO.0000000000000361
Msaouel, Pavlos, et al. "Recent developments in the management of germ cell tumors." Current opinion in oncology vol. 29,3 (2017): 172-178. doi: https://doi.org/10.1097/CCO.0000000000000361
Msaouel P, Bilen MA, Zhang M, Campbell M, Wang J, Tu SM. Recent developments in the management of germ cell tumors. Curr Opin Oncol. 2017 May;29(3):172-178. doi: 10.1097/CCO.0000000000000361. PMID: 28151756; PMCID: PMC5538942.
Copy Download .nbib Format: NLM
Neurological paraneoplastic syndromes: an update.

Current opinion in oncology

Berzero G, Psimaras D.
PMID: 30124520
Curr Opin Oncol. 2018 Nov;30(6):359-367. doi: 10.1097/CCO.0000000000000479.

PURPOSE OF REVIEW: To describe recent advances in the diagnosis and treatment of paraneoplastic neurological syndromes (PNS).RECENT FINDINGS: PNS are rare complications of cancer caused by an immune cross-reaction between antigens expressed by tumor cells and neurons. The target...

Cite
Berzero G, Psimaras D. Neurological paraneoplastic syndromes: an update. Curr Opin Oncol. 2018;30(6):359-367doi: 10.1097/CCO.0000000000000479.
Berzero, G., & Psimaras, D. (2018). Neurological paraneoplastic syndromes: an update. Current opinion in oncology, 30(6), 359-367. https://doi.org/10.1097/CCO.0000000000000479
Berzero, Giulia, and Psimaras, Dimitri. "Neurological paraneoplastic syndromes: an update." Current opinion in oncology vol. 30,6 (2018): 359-367. doi: https://doi.org/10.1097/CCO.0000000000000479
Berzero G, Psimaras D. Neurological paraneoplastic syndromes: an update. Curr Opin Oncol. 2018 Nov;30(6):359-367. doi: 10.1097/CCO.0000000000000479. PMID: 30124520.
Copy Download .nbib Format: NLM
Bibliography. Head and neck. Current world literature.

Current opinion in oncology

[No authors listed]
PMID: 22495782
Curr Opin Oncol. 2012 May;24(3):345-9. doi: 10.1097/CCO.0b013e328352df9c.

No abstract available.

Cite
Bibliography. Head and neck. Current world literature. Curr Opin Oncol. 2012;24(3):345-9doi: 10.1097/CCO.0b013e328352df9c.
(2012). Bibliography. Head and neck. Current world literature. Current opinion in oncology, 24(3), 345-9. https://doi.org/10.1097/CCO.0b013e328352df9c
"Bibliography. Head and neck. Current world literature." Current opinion in oncology vol. 24,3 (2012): 345-9. doi: https://doi.org/10.1097/CCO.0b013e328352df9c
Bibliography. Head and neck. Current world literature. Curr Opin Oncol. 2012 May;24(3):345-9. doi: 10.1097/CCO.0b013e328352df9c. PMID: 22495782.
Copy Download .nbib Format: NLM
Supportive care in cancer: quo vadis.

Current opinion in oncology

Klastersky JA.
PMID: 29794810
Curr Opin Oncol. 2018 Jul;30(4):203-204. doi: 10.1097/CCO.0000000000000457.

No abstract available.

Cite
Klastersky JA. Supportive care in cancer: quo vadis. Curr Opin Oncol. 2018;30(4):203-204doi: 10.1097/CCO.0000000000000457.
Klastersky, J. A. (2018). Supportive care in cancer: quo vadis. Current opinion in oncology, 30(4), 203-204. https://doi.org/10.1097/CCO.0000000000000457
Klastersky, Jean A. "Supportive care in cancer: quo vadis." Current opinion in oncology vol. 30,4 (2018): 203-204. doi: https://doi.org/10.1097/CCO.0000000000000457
Klastersky JA. Supportive care in cancer: quo vadis. Curr Opin Oncol. 2018 Jul;30(4):203-204. doi: 10.1097/CCO.0000000000000457. PMID: 29794810.
Copy Download .nbib Format: NLM
WITHDRAWN:New PET imaging agents in the management of solid cancers.

Current opinion in oncology

Garcia C, Gebhart G, Flamen P.
PMID: 22410459
Curr Opin Oncol. 2012 Mar 23; doi: 10.1097/CCO.0b013e3283528116. Epub 2012 Mar 23.

Ahead of Print article withdrawn by publisher.

Cite
Garcia C, Gebhart G, Flamen P. WITHDRAWN:New PET imaging agents in the management of solid cancers. Curr Opin Oncol. 2012;doi: 10.1097/CCO.0b013e3283528116.
Garcia, C., Gebhart, G., & Flamen, P. (2012). WITHDRAWN:New PET imaging agents in the management of solid cancers. Current opinion in oncology, . https://doi.org/10.1097/CCO.0b013e3283528116
Garcia, Camilo, et al. "WITHDRAWN:New PET imaging agents in the management of solid cancers." Current opinion in oncology vol. (2012). doi: https://doi.org/10.1097/CCO.0b013e3283528116
Garcia C, Gebhart G, Flamen P. WITHDRAWN:New PET imaging agents in the management of solid cancers. Curr Opin Oncol. 2012 Mar 23; doi: 10.1097/CCO.0b013e3283528116. Epub 2012 Mar 23. PMID: 22410459.
Copy Download .nbib Format: NLM
Editorial: The challenge of treating and investigating rare gynaecologic cancers.

Current opinion in oncology

Lok C, Amant F.
PMID: 34175856
Curr Opin Oncol. 2021 Sep 01;33(5):432-434. doi: 10.1097/CCO.0000000000000761.

No abstract available.

Cite
Lok C, Amant F. Editorial: The challenge of treating and investigating rare gynaecologic cancers. Curr Opin Oncol. 2021;33(5):432-434doi: 10.1097/CCO.0000000000000761.
Lok, C., & Amant, F. (2021). Editorial: The challenge of treating and investigating rare gynaecologic cancers. Current opinion in oncology, 33(5), 432-434. https://doi.org/10.1097/CCO.0000000000000761
Lok, Christianne, and Amant, Frédéric. "Editorial: The challenge of treating and investigating rare gynaecologic cancers." Current opinion in oncology vol. 33,5 (2021): 432-434. doi: https://doi.org/10.1097/CCO.0000000000000761
Lok C, Amant F. Editorial: The challenge of treating and investigating rare gynaecologic cancers. Curr Opin Oncol. 2021 Sep 01;33(5):432-434. doi: 10.1097/CCO.0000000000000761. PMID: 34175856.
Copy Download .nbib Format: NLM
State of the art and future directions in the systemic treatment of medullary thyroid cancer.

Current opinion in oncology

Jager EC, Broekman KE, Kruijff S, Links TP.
PMID: 34669647
Curr Opin Oncol. 2022 Jan 01;34(1):1-8. doi: 10.1097/CCO.0000000000000798.

PURPOSE OF REVIEW: Systemic treatment is the only therapeutic option for patients with progressive, metastatic medullary thyroid cancer (MTC). Since the discovery of the rearranged during transfection (RET) proto-oncogene (100% hereditary, 60-90% sporadic MTC), research has focused on finding...

Cite
Jager EC, Broekman KE, Kruijff S, et al. State of the art and future directions in the systemic treatment of medullary thyroid cancer. Curr Opin Oncol. 2022;34(1):1-8doi: 10.1097/CCO.0000000000000798.
Jager, E. C., Broekman, K. E., Kruijff, S., & Links, T. P. (2022). State of the art and future directions in the systemic treatment of medullary thyroid cancer. Current opinion in oncology, 34(1), 1-8. https://doi.org/10.1097/CCO.0000000000000798
Jager, Eline C, et al. "State of the art and future directions in the systemic treatment of medullary thyroid cancer." Current opinion in oncology vol. 34,1 (2022): 1-8. doi: https://doi.org/10.1097/CCO.0000000000000798
Jager EC, Broekman KE, Kruijff S, Links TP. State of the art and future directions in the systemic treatment of medullary thyroid cancer. Curr Opin Oncol. 2022 Jan 01;34(1):1-8. doi: 10.1097/CCO.0000000000000798. PMID: 34669647.
Copy Download .nbib Format: NLM
Lung cancer screening: a critical appraisal.

Current opinion in oncology

Kian W, Zemel M, Levitas D, Alguayn W, Remilah AA, Rahman NA, Peled N.
PMID: 34652284
Curr Opin Oncol. 2022 Jan 01;34(1):36-43. doi: 10.1097/CCO.0000000000000801.

PURPOSE OF REVIEW: The recently published large-scale NELSON trial showed a reduction in lung cancer (LC) mortality with the use of low-dose computed tomography (LDCT) in high-risk patients. This is the first such European-based trial to mirror the results...

Cite
Kian W, Zemel M, Levitas D, et al. Lung cancer screening: a critical appraisal. Curr Opin Oncol. 2022;34(1):36-43doi: 10.1097/CCO.0000000000000801.
Kian, W., Zemel, M., Levitas, D., Alguayn, W., Remilah, A. A., Rahman, N. A., & Peled, N. (2022). Lung cancer screening: a critical appraisal. Current opinion in oncology, 34(1), 36-43. https://doi.org/10.1097/CCO.0000000000000801
Kian, Waleed, et al. "Lung cancer screening: a critical appraisal." Current opinion in oncology vol. 34,1 (2022): 36-43. doi: https://doi.org/10.1097/CCO.0000000000000801
Kian W, Zemel M, Levitas D, Alguayn W, Remilah AA, Rahman NA, Peled N. Lung cancer screening: a critical appraisal. Curr Opin Oncol. 2022 Jan 01;34(1):36-43. doi: 10.1097/CCO.0000000000000801. PMID: 34652284.
Copy Download .nbib Format: NLM
The conquest of lung cancer in Central Europe.

Current opinion in oncology

Klastersky JA.
PMID: 34652285
Curr Opin Oncol. 2022 Jan 01;34(1):32-35. doi: 10.1097/CCO.0000000000000803.

PURPOSE OF REVIEW: Discussed the main approaches for lung control and point out differences among Central Europe and other countries.RECENT FINDINGS: Three main approaches exist: smoking ban, early computed tomography screening and access to novel therapies; major differences exist...

Cite
Klastersky JA. The conquest of lung cancer in Central Europe. Curr Opin Oncol. 2022;34(1):32-35doi: 10.1097/CCO.0000000000000803.
Klastersky, J. A. (2022). The conquest of lung cancer in Central Europe. Current opinion in oncology, 34(1), 32-35. https://doi.org/10.1097/CCO.0000000000000803
Klastersky, Jean A. "The conquest of lung cancer in Central Europe." Current opinion in oncology vol. 34,1 (2022): 32-35. doi: https://doi.org/10.1097/CCO.0000000000000803
Klastersky JA. The conquest of lung cancer in Central Europe. Curr Opin Oncol. 2022 Jan 01;34(1):32-35. doi: 10.1097/CCO.0000000000000803. PMID: 34652285.
Copy Download .nbib Format: NLM
Depression and cancer: recent data on clinical issues, research challenges and treatment approaches.

Current opinion in oncology

Reich M.
PMID: 18525327
Curr Opin Oncol. 2008 Jul;20(4):353-9. doi: 10.1097/CCO.0b013e3282fc734b.

PURPOSE OF REVIEW: Clinical guidelines for depression screening, assessment and management in the oncologic field and palliative care are becoming paramount in routine cancer care. This psychiatric comorbidity has several impacts on quality of life, anticancer treatment compliance, hospital...

Cite
Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol. 2008;20(4):353-9doi: 10.1097/CCO.0b013e3282fc734b.
Reich, M. (2008). Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Current opinion in oncology, 20(4), 353-9. https://doi.org/10.1097/CCO.0b013e3282fc734b
Reich, Michel. "Depression and cancer: recent data on clinical issues, research challenges and treatment approaches." Current opinion in oncology vol. 20,4 (2008): 353-9. doi: https://doi.org/10.1097/CCO.0b013e3282fc734b
Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol. 2008 Jul;20(4):353-9. doi: 10.1097/CCO.0b013e3282fc734b. PMID: 18525327.
Copy Download .nbib Format: NLM
Teaching supportive care: what is the core curriculum?.

Current opinion in oncology

Herrstedt J, Molassiotis A.
PMID: 34100467
Curr Opin Oncol. 2021 Jul 01;33(4):279-286. doi: 10.1097/CCO.0000000000000735.

PURPOSE OF REVIEW: Cancer treatment options have developed rapidly in the past years. Targeted- and immune therapy have resulted in additional supportive care needs. This review describes a teaching program in supportive care.RECENT FINDINGS: Supportive care begins at the...

Cite
Herrstedt J, Molassiotis A. Teaching supportive care: what is the core curriculum?. Curr Opin Oncol. 2021;33(4):279-286doi: 10.1097/CCO.0000000000000735.
Herrstedt, J., & Molassiotis, A. (2021). Teaching supportive care: what is the core curriculum?. Current opinion in oncology, 33(4), 279-286. https://doi.org/10.1097/CCO.0000000000000735
Herrstedt, Jørn, and Molassiotis, Alex. "Teaching supportive care: what is the core curriculum?." Current opinion in oncology vol. 33,4 (2021): 279-286. doi: https://doi.org/10.1097/CCO.0000000000000735
Herrstedt J, Molassiotis A. Teaching supportive care: what is the core curriculum?. Curr Opin Oncol. 2021 Jul 01;33(4):279-286. doi: 10.1097/CCO.0000000000000735. PMID: 34100467.
Copy Download .nbib Format: NLM
Prevention: editorial overview.

Current opinion in oncology

Levin B.
PMID: 10505779
Curr Opin Oncol. 1999 Sep;11(5):401.

No abstract available.

Cite
Levin B. Prevention: editorial overview. Curr Opin Oncol. 1999;11(5):401
Levin, B. (1999). Prevention: editorial overview. Current opinion in oncology, 11(5), 401.
Levin. "Prevention: editorial overview." Current opinion in oncology vol. 11,5 (1999): 401.
Levin B. Prevention: editorial overview. Curr Opin Oncol. 1999 Sep;11(5):401. PMID: 10505779.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 115 entries